During the past decade, Esra Giray conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Esra Giray" are "Lymphedema of Upper Arm" (2 trials), "Stroke" (2 trials), "Breast Cancer" (1 trials), "Cerebral Palsy" (1 trials) and "Hypersalivation" (1 trials). Many other conditions were trialed in "Esra Giray" in a lesser frequency.

Most popular intervention types in "Esra Giray" are "Other" (5 trials), "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Actical accelerometers (Philips Respironics)" (1 trials), "Botulinum Toxin" (1 trials), "Communication Function Classification System (CFCS)" (1 trials), "Complex decongestive therapy phase 1" (1 trials) and "Drooling Frequency and Severity Scale" (1 trials). Other intervention names were less common.

The vast majority of trials in "Esra Giray" are 3 trials for "Female" genders and 2 trials for "All" genders.

Currently, there are NaN active trials in "Esra Giray". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Esra Giray, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Esra Giray, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".